Pouessel, D. ; Neuzillet, Y. ; Mertens, L. S. ; van der Heijden, M. S. ; de Jong, J. ; Sanders, J. ; Peters, D. ; Leroy, K. 
; Manceau, A. ; Maille, P. ; Soyeux, P. ; Moktefi, A. ; Semprez, F. ; Vordos, D. ; de la Taille, A. ; Hurst, C. D. ; Tomlinson, D. C. ; Harnden, P. ; Bostrom, P. J. ; Mirtti, T. ; Horenblas, S. ; Loriot, Y. ; Houédé, N. ; Chevreau, C. ; Beuzeboc, P. ; Shariat, S. F. ; Sagalowsky, A. I. ; Ashfaq, R. ; Burger, M. ; Jewett, M. A. S. ; Zlotta, A. R. ; Broeks, A. ; Bapat, B. ; Knowles, M. A. ; Lotan, Y. ; van der Kwast, T. H. ; Culine, S. ; Allory, Y. ; van Rhijn, B. W. G.
; Manceau, A. ; Maille, P. ; Soyeux, P. ; Moktefi, A. ; Semprez, F. ; Vordos, D. ; de la Taille, A. ; Hurst, C. D. ; Tomlinson, D. C. ; Harnden, P. ; Bostrom, P. J. ; Mirtti, T. ; Horenblas, S. ; Loriot, Y. ; Houédé, N. ; Chevreau, C. ; Beuzeboc, P. ; Shariat, S. F. ; Sagalowsky, A. I. ; Ashfaq, R. ; Burger, M. ; Jewett, M. A. S. ; Zlotta, A. R. ; Broeks, A. ; Bapat, B. ; Knowles, M. A. ; Lotan, Y. ; van der Kwast, T. H. ; Culine, S. ; Allory, Y. ; van Rhijn, B. W. G. Tumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatment
Pouessel, D., Neuzillet, Y., Mertens, L. S., van der Heijden, M. S., de Jong, J., Sanders, J., Peters, D., Leroy, K., Manceau, A., Maille, P., Soyeux, P., Moktefi, A., Semprez, F., Vordos, D., de la Taille, A., Hurst, C. D., Tomlinson, D. C. , Harnden, P., Bostrom, P. J., Mirtti, T., Horenblas, S., Loriot, Y., Houédé, N., Chevreau, C., Beuzeboc, P., Shariat, S. F., Sagalowsky, A. I., Ashfaq, R., Burger, M., Jewett, M. A. S., Zlotta, A. R., Broeks, A., Bapat, B., Knowles, M. A., Lotan, Y., van der Kwast, T. H., Culine, S., Allory, Y. and van Rhijn, B. W. G.
(2016)
Tumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatment.
Annals of Oncology 27 (7), pp. 1311-1316.
Date of publication of this fulltext: 17 Mar 2020 11:34
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Annals of Oncology | ||||
| Publisher: | Oxford Univ. Press | ||||
|---|---|---|---|---|---|
| Place of Publication: | OXFORD | ||||
| Volume: | 27 | ||||
| Number of Issue or Book Chapter: | 7 | ||||
| Page Range: | pp. 1311-1316 | ||||
| Date | 2016 | ||||
| Institutions | Medicine > Lehrstuhl für Urologie | ||||
| Identification Number |
| ||||
| Keywords | RADICAL CYSTECTOMY; UROTHELIAL CARCINOMA; CHEMOTHERAPY; EXPRESSION; TRIAL; GRADE; FGFR3; mutations; heterogeneity; bladder; cancer; targeted therapy | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 42644 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric